NCT03774836View on ClinicalTrials.gov

Tramadol Versus Placebo and Morphine in the Management of Post-Operative Pain Abdominoplasty

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

December 14, 2018

Primary Completion Date

May 30, 2019

Study Completion Date

June 30, 2019

Conditions
Pain Management
Interventions
DRUG

Tramadol

IV Tramadol 50 mg, given at Hours 0, 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, and 44

DRUG

Morphine

Morphine 4 mg, given at Hours 0, 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, and 44

OTHER

Placebo

Placebo, given at Hours 0, 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, and 44

Trial Locations (3)

77004

Hermann Drive Research, Houston

78229

Endeavor Clinical Trials, San Antonio

91105

Lotus Clinical Research, Pasadena

Sponsors
All Listed Sponsors
lead

Avenue Therapeutics, Inc.

INDUSTRY

NCT03774836 - Tramadol Versus Placebo and Morphine in the Management of Post-Operative Pain Abdominoplasty | Biotech Hunter | Biotech Hunter